» Articles » PMID: 25745529

A Review of the Surveillance Systems of Influenza in Selected Countries in the Tropical Region

Overview
Journal Pan Afr Med J
Date 2015 Mar 7
PMID 25745529
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza viruses cause annual epidemics of respiratory tract disease that affect all age groups. Many developing countries do not have an influenza surveillance system or adequate laboratory capacity for virus detection. The objective of this study was to describe the influenza surveillance systems in the different countries in the tropics and to identify outstanding research needs. A questionnaire was designed and sent to 52 NICs and MoHs in the different countries in tropical Asia and Africa to gather information on the surveillance systems, sentinel sites, specimen and data collection, and laboratory testing. Replies were received from 32 NICs and MoHs (61.5% response)--17 were located in tropical Asia and 15 in Africa. There are 20 WHO recognized NICs in tropical Asia and 14 in tropical Africa, all with virus isolation and polymerase chain reaction (PCR) testing capacity. Of the Asian countries, only Hong Kong and Singapore reported that the patient population from the sites represents the broader community. In tropical Africa, only Senegal has sentinel sites distributed all over the country contributing to the geographic representativeness of the surveillance system. The rest of the countries in Africa have just established their influenza surveillance system in the past decade and are working toward geographic expansion of the ILI and SARI sites. Limited laboratory capacity or infrastructure to perform influenza surveillance makes difficult to justify the importance of influenza vaccine or other influenza control measures as a strategy for improving population health in the tropical region.

Citing Articles

Zoonotic spillover and viral mutations from low and middle-income countries: improving prevention strategies and bridging policy gaps.

Haq Z, Nazir J, Manzoor T, Saleem A, Hamadani H, Khan A PeerJ. 2024; 12:e17394.

PMID: 38827296 PMC: 11144393. DOI: 10.7717/peerj.17394.


National influenza surveillance systems in five European countries: a qualitative comparative framework based on WHO guidance.

de Fougerolles T, Damm O, Ansaldi F, Chironna M, Crepey P, de Lusignan S BMC Public Health. 2022; 22(1):1151.

PMID: 35681199 PMC: 9178537. DOI: 10.1186/s12889-022-13433-0.


The epidemiology of seasonal influenza after the 2009 influenza pandemic in Africa: a systematic review.

Lagare A, Rajatonirina S, Testa J, Mamadou S Afr Health Sci. 2021; 20(4):1514-1536.

PMID: 34394213 PMC: 8351825. DOI: 10.4314/ahs.v20i4.5.


Prevalence of human respiratory syncytial virus, parainfluenza and adenoviruses in East Africa Community partner states of Kenya, Tanzania, and Uganda: A systematic review and meta-analysis (2007-2020).

Umuhoza T, Bulimo W, Oyugi J, Musabyimana J, Kinengyere A, Mancuso J PLoS One. 2021; 16(4):e0249992.

PMID: 33905425 PMC: 8078816. DOI: 10.1371/journal.pone.0249992.


Systematic analysis of the scientific literature on population surveillance.

Gonzalez-Alcaide G, Llorente P, Ramos-Rincon J Heliyon. 2020; 6(10):e05141.

PMID: 33029562 PMC: 7528878. DOI: 10.1016/j.heliyon.2020.e05141.


References
1.
Zambon M . Epidemiology and pathogenesis of influenza. J Antimicrob Chemother. 2000; 44 Suppl B:3-9. DOI: 10.1093/jac/44.suppl_2.3. View

2.
Couch R . Influenza: prospects for control. Ann Intern Med. 2000; 133(12):992-8. DOI: 10.7326/0003-4819-133-12-200012190-00015. View

3.
Cox R, Brokstad K, Ogra P . Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol. 2004; 59(1):1-15. DOI: 10.1111/j.0300-9475.2004.01382.x. View

4.
Schmidt A . Antiviral therapy for influenza : a clinical and economic comparative review. Drugs. 2004; 64(18):2031-46. DOI: 10.2165/00003495-200464180-00003. View